GTGabriel Thorens

Gabriel Thorens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriel Thorens has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland

    by T. Aboulafia-Brakha, A. Buchard, C. Mabilais, S. Alaux, C. Amberger, L. Furtado, F. Seragnoli, J-F Briefer, G. Thorens, M. Sabé, et al.


  • Open Access

    Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study

    by Mylène Cheng, Tatiana Aboulafia-Brakha, Albert Buchard, Raya Boyanova Anastasova, Lea Girani, Anna Breitenmoser, Sylvie Alaux, Cedric Mabilais, Caroline Amberger, Federico Seragnoli, et al.

    Classic psychedelics such as lysergic acid diethylamide (LSD) and psilocybin induce mild cardiovascular activation in addition to their psychological effects. While these effects are well described in healthy adults, little is known about their dynamics in clinical populations undergoing psychedelic-assisted psychotherapy. This retrospective, observational, single-center study analyzed routinely collected data from 30 patients (mean age = 51.56 ± 12.19 years; 15/30 female) treated under compassionate use for treatment-resistant depression or anxiety disorders. Participants received either LSD (100–200 mcg) or psilocybin (15–30 mg) in supervised outpatient sessions. Heart rate and self-rated anxiety (VAS 0–100) were recorded at seven intervals from 30 to 300 min post-administration. Linear mixed models examined heart rate trajectories over time × substance, controlling for age and, in a second model, perceived anxiety. Linear mixed models revealed no significant main effect of time (F(6, 77.25) = 0.76, p = 0.60) or substance (F(1, 30.82) = 0.66, p = 0.42), but a significant time × substance interaction (F(6, 77.25) = 3.03, p = 0.01). LSD was associated with a delayed but sustained increase in heart rate peaking at 3–4 h, whereas psilocybin showed an earlier decline. These patterns persisted after adjustment for age and anxiety, and anxiety did not significantly modify the relationship between time and substance. No serious cardiovascular adverse events occurred. These preliminary findings suggest that LSD and psilocybin may produce distinct temporal patterns of cardiovascular activation in clinical settings. However, interpretation should be cautious due to the retrospective design, small sample size, and dose imbalance between substances.

  • Open Access

    Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

    by Mathilda Mercier, Cedric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia-Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler

    Psychedelic substances have experienced a resurgence of clinical interest in recent years, particularly for their promising effects in the treatment of psychiatric disorders such as depression and anxiety. While evidence regarding their role in chronic pain management remains limited, emerging studies suggest potential therapeutic benefits. This case report describes a patient with persistent somatoform pain disorder and recurrent depressive disorder who underwent four sessions of psilocybin-assisted psychotherapy. The intervention was associated with a reduction in the negative impact of pain on daily life, increased pain acceptance, improved quality of life, and reduction in depressive symptoms. These findings contribute to the growing body of literature suggesting that psychedelics, when combined with psychotherapy, may offer a novel and holistic approach to the treatment of chronic pain. Further controlled studies are needed to explore the safety, efficacy, and underlying mechanisms.

  • Open Access

    Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder

    by Laure Cazorla, Sylvie Alaux, Caroline Amberger, Cédric Mabilais, Leonice Furtado, Albert Buchard, Gabriel Thorens, Louise Penzenstadler, Daniele Zullino, Tatiana Aboulafia Brakha

    Despite growing evidence supporting the efficacy of LSD-assisted psychotherapy in treating major depressive disorder (MDD), identifying reliable psychopharmacological biomarkers remains necessary. Oxytocin, a neuropeptide implicated in social bonding and flexibility, is a promising candidate due to its release following serotonergic psychedelic administration in healthy individuals; however, its dynamics in psychiatric populations are currently unexplored. This observational pilot study aimed to characterize salivary oxytocin dynamics during a single LSD-assisted psychotherapy session in our patients with treatment-resistant MDD. Participants received 100 or 150 µg LSD, and salivary oxytocin was measured at baseline, 60, 90, and 180 min post-LSD. Concurrently, participants rated subjective drug intensity (0–10 scale) at 60, 90, and 180 min. A linear mixed model revealed significant variation of oxytocin levels over time. Perceived psychedelic intensity also significantly varied over time. This supports oxytocin as a potential biomarker. Larger, controlled trials are warranted to replicate these findings and clarify the mechanistic links between oxytocin dynamics and clinical outcomes, including changes in depressive symptoms and mental flexibility.

  • Open Access

    Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder

    by Laurie Cazorla, Sylvie Alaux, Caroline Amberger, Cedric Mabilais, Leonice Furtado, Albert Buchard, Gabriel Thorens, Louise Penzenstadler, Daniele Zullino, Tatiana Aboulafia Brakha

    Despite growing evidence supporting the efficacy of LSD-assisted psychothera-py in treating major depressive disorder (MDD), identifying reliable psychopharmacolog-ical biomarkers remains necessary. Oxytocin, a neuropeptide implicated in social bonding and flexibility, is a promising candidate due to its release following serotonergic psyche-delic administration in healthy individuals; however, its dynamics in psychiatric popula-tions are currently unexplored. This observational pilot study aimed to characterize sali-vary oxytocin dynamics during a single LSD-assisted psychotherapy session in our pa-tients with treatment-resistant MDD. Participants received 100 or 150 µg LSD and salivary oxytocin was measured at baseline, 60, 90, and 180 minutes post-LSD. Concurrently, par-ticipants rated subjective drug intensity (0-10 scale) at 60, 90, and 180 minutes. A linear mixed model revealed significant variation of oxytocin levels over time. Perceived psy-chedelic intensity also significantly varied over time. This supports oxytocin as a potential biomarker. Larger, controlled trials are warranted to replicate these findings and clarify mechanistic links between oxytocin dynamics and clinical outcomes, including changes in depressive symptoms and mental flexibility.

  • Open Access

    Metacognitive Feelings of Epistemic Gain are Central to the Understanding of Psychedelic-Induced Mystical-Type Experiences

    by Federico Seragnoli, Fabienne Picard, Gabriel Thorens, Albert Buchard, Megan Geyer, Angela Abatista, Polina Ponomarenko, Cyril Petignat, Marco Riccardi, Maëlle Bisson, et al.

    Purpose: Despite the presence of mystical-type experiences in psychedelic-assisted therapy (PAT), an understanding of the cognitive processes involved is still lacking. Guided by theory and empirical research, we hypothesized a cognitive-grounded perspective based on current metacognition models to promote the understanding of the psychological processes involved in mystical-type experiences induced by psychedelic substances. Method: The definition of metacognition is reviewed, with a particular focus on its role in psychotherapy and how it is used to understand altered states of consciousness such as meditation, lucid dreaming, and ecstatic epilepsy. We theoretically posited that metacognition is affected by psychedelic substance intake. We used metacognition models to understand the noetic facet of the mystical-type experience potentially induced by psychedelics, focusing on insight processes and proposing a specific definition of the “Aha!”/ “Eureka!” experience as a metacognitive feeling of epistemic gain. Results: We hypothesized that the noetic feature of the psychedelic-induced mystical-type experience might account for the activation of procedural, performance-based, outcome-related metacognitive feelings, which are metacognitive feelings of epistemic gain. Conclusions: We review the potential implications of this framework within PAT in relation to clinically relevant aspects such as therapeutic preparation, intention setting, and outcome and integration; the use of music; traumatic memory recall; therapists’ self-experience; suggestibility; and spiritual bypassing. Ultimately, we describe different lines of further research.


  • Open Access

    Physical Activity as a Predictor of Internet Gaming Disorder in a Swiss Male Cohort (C-SURF): L’activité physique comme prédicteur des troubles liés aux jeux vidéo en ligne dans une cohorte de jeunes hommes suisses (C-SURF)

    by Adam Nowotarski, Stephane Rothen, Filip Kasina, Daniele Zullino, Gabriel Thorens

    History and Objectives: This study addresses the increasing global concerns surrounding Internet gaming disorder (IGD) by exploring their connection to physical activity (PA) as a potential preventive and early intervention measure. The research aims to examine the relationship between PA and the progression of IGD. Methods: Longitudinal data from the Cohort research on Substance Use Risk Factors involving young Swiss men undergoing army conscription was employed. PA levels were assessed using the International PA Questionnaire (IPAQ), while the Game Addiction Scale (GAS) and Compulsive Internet Use Scale determined IGD presence. Analysis involved zero-inflated negative binomial regression models. Results: Higher PA levels were associated with lower IGD risk. Notably, individuals engaging in high physical exercise exhibited a lower IGD prevalence compared to those with moderate or low activity levels. Discussion: The study suggests that intensive physical exercise might serve as a preventive strategy against developing IGD. This protective effect could stem from various mechanisms. However, the study's limitations, such as a male-only sample and a small low-activity group, should be considered when interpreting results. Conclusion: The longitudinal study demonstrates the positive influence of intense physical exercise on mitigating gaming-related issues. These findings underscore the potential of PA interventions in addressing the growing problem of IGDs and their impact on health. Further research is necessary to uncover underlying mechanisms behind the PA–IGD relationship and validate these findings across diverse demographics.


  • Open Access

    Cannabis Consumers’ View of Regulated Access to Recreational Cannabis: A Multisite Survey in Switzerland

    by Monika Müller, Edith Paula Mészáros, Marc Walter, Lavinia Baltes-Flückiger, Marcus Herdener, Reto Auer, Gabriel Thorens, Stephane Rothen, Carlos Nordt, Daniele Zullino

    Introduction: There is considerable effort in legalizing recreational use of cannabis globally. The successful implementation of a program of regulated access to recreational cannabis (PRAC) depends on the consumers’ engagement. The aim of this study was to examine the acceptability of twelve different regulatory aspects by cannabis users including those obtaining cannabis from the illicit market and vulnerable populations such as young adults and problematic users. Methods: The current study is a multisite online survey conducted in Switzerland. A total of 3,132 adult Swiss residents who consumed cannabis within the previous 30 days represented the studied population. Mean age was 30.5 years, 80.5% were men, and 64.2% of the participants stated that they always or often obtain cannabis from the illicit market. We described consumers’ acceptability of twelve regulatory aspects concerning THC content control, disclosure of sensitive personal data, security aspects, and follow-up procedures by applying descriptive statistics and multiple regression models. Results: THC content regulation showed most discrepancy with 89.4% of the participants stating to engage in a PRAC if five different THC contents were available as compared to 54% if only 12% THC was available. The least accepted regulatory aspect was disposal of contact details with an acceptability rate of 18.1%. Consumers mainly obtaining cannabis from the illicit market, young adults, and problematic users showed similar acceptability patterns. Participants obtaining cannabis from the illicit market were more likely to engage in a PRAC if five different THC contents were available as compared to participants obtaining cannabis from other sources (OR 1.94, 95% CI: 1.53–2.46). Conclusion: A carefully designed PRAC that takes into account the consumers’ perspective is likely to transfer them to the regulated market and to engage vulnerable populations. We cannot recommend the distribution of cannabis with only 12% THC content as this is unlikely to engage the target population.


  • Open Access

    Professional football players as role models in smoking prevention

    by Gerard Calzada, Cdric Cibotto, Julien Manetti, Aaron-Maria Rudolf, David Folino, Stphane Rothen, Gabriel Thorens, Daniele Zullino

  • Open Access

    Game Addiction Scale Assessment Through a Nationally Representative Sample of Young Adult Men: Item Response Theory Graded–Response Modeling

    by Yasser Khazaal, Kyrre Breivik, Joel Billieux, Daniele Zullino, Gabriel Thorens, Sophia Achab, Gerhard Gmel, Anne Chatton

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The 7-item Game Addiction Scale (GAS) has been validated under standard confirmatory factor analysis and has good psychometric properties. Whether this scale satisfies the necessary conditions for consideration by item response theory (IRT) modeling is unknown. However, section 3 of the DSM-5 recently proposed criteria to define Internet gaming disorder (IGD) to promote research on this possible condition. Objective: We aimed to (1) to analyze the GAS scale in the context of IRT (graded-response) modeling; (2) investigate differential item functioning (DIF), a feature of IRT modeling, in 2 subsamples; and (3) contribute to the ongoing (IGD) debate related to the validity of the DSM-5 criteria, using the GAS scale items as a proxy. Methods: Two large representative samples of Swiss men (3320 French speaking and 2670 German speaking) were assessed with the GAS. Results: All items had high discrimination parameters. Relapse, conflict, withdrawal, and problems (loss of interests) were the GAS items endorsed more frequently in more severe IGD stages, whereas items related to tolerance, salience (preoccupation), and mood modification (escape) were endorsed more widely among the participants (including in less severe IGD stages). Several DIF effects were found but were classified as negligible. Conclusions: The results of the analyses support the notion that an IRT approach is recommended for GAS and that this scale is also a reliable instrument for measuring game addiction. Clinical Trial: Not applicable